Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Einas Elmahi
Observed names:
E Elmahi,
E. Elmahi,
Elmahi, Einas
Observed institutions:
Northampton General Hospital,
John Radcliffe Hospital,
National Institute for Health and Care Research,
University of Oxford,
Northampton General Hospital NHS Trust,
Renewable Energy Alaska Project,
Canadian Critical Care Trials Group
show all 7
ORCID:
0000-0001-7707-9456
Observed ORCID:
0000-0001-7707-9456
OpenAlex ID:
A5049554502
Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19
2020
·
Peter Horby
, Marion Mafham
, et al.
·
New England Journal of Medicine
·
1,468
Lopinavir–ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2020
·
Peter W Horby
, Marion Mafham
, et al.
·
The Lancet
·
709
PDF
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2021
·
Eugenia Abaleke
, Mustafa Abbas
, et al.
·
The Lancet
·
533
PDF
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
2021
·
Obbina Abani
, Ali Abbas
, et al.
·
The Lancet
·
493
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2022
·
Obbina Abani
, Ali Abbas
, et al.
·
The Lancet
·
369
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
2022
·
Obbina Abani
, Ali Abbas
, et al.
·
The Lancet
·
324
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2021
·
Obbina Abani
, Ali Abbas
, et al.
·
The Lancet
·
290
Effect of Convalescent Plasma on Organ Support–Free Days in Critically Ill Patients With COVID-19
2021
·
Hesham Abdelhady
, Marwa Abdelrazik
, et al.
·
JAMA
·
210
PDF
Effect of Antiplatelet Therapy on Survival and Organ Support–Free Days in Critically Ill Patients With COVID-19
2022
·
Simin Florescu
, Delia Stanciu
, et al.
·
JAMA
·
146
PDF
Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial
2022
·
Simin Florescu
, Delia Stanciu
, et al.
·
JAMA
·
136
PDF
Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
2023
·
Obbina Abani
, Ali Abbas
, et al.
·
The Lancet
·
129
Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial
2021
·
Yaseen M. Arabi
, Anthony C. Gordon
, et al.
·
Intensive Care Medicine
·
99
PDF
Effect of Dexamethasone in Hospitalized Patients with COVID-19 – Preliminary Report
2020
·
Peter Horby
, Wee Shiong Lim
, et al.
·
Repository@Nottingham (University of Nottingham)
·
98
Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support–Free Days in Patients Hospitalized With COVID-19
2023
·
Simin Florescu
, Delia Stanciu
, et al.
·
JAMA
·
63
PDF
Intravenous Vitamin C for Patients Hospitalized With COVID-19
2023
·
The LOVIT-COVID Investigators, on behalf of the Canadian Critical Care Trials Group, and the REMAP-CAP Investigators
, Simin Florescu
, et al.
·
JAMA
·
53
PDF
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2023
·
O Abani
, A Abbas
, et al.
·
The Lancet Diabetes & Endocrinology
·
41
PDF
Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial
2024
·
Saul N Faust
, Richard Haynes
, et al.
·
The Lancet Child & Adolescent Health
·
39
PDF
Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2025
·
O Abani
, A Abbas
, et al.
·
The Lancet Infectious Diseases
·
12
PDF
Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
2025
·
O. Abani
, A. Abbas
, et al.
·
EClinicalMedicine
·
5
Does self-reported pregnancy loss identify women at risk of an adverse cardiovascular phenotype in later life? Insights from UK Biobank
2019
·
Einas Elmahi
, Mihir M. Sanghvi
, et al.
·
PLoS ONE
·
5
PDF
Do Young Women Need Treatment for Hypertension After Pregnancy Complications?
2018
·
Christina Y. L. Aye
, Einas Elmahi
, et al.
·
Journal of the American Heart Association
·
2
Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2025
·
O Abani
, A Abbas
, et al.
·
The Lancet Infectious Diseases
PDF
Effect of hydroxychloroquine in hospitalized patients with Covid-19
2020
·
Peter Horby
, Marion Mafham
, et al.
·
Newcastle University ePrints (Newcastle Univesity)
P2249Does self-reported pregnancy loss identify women at risk of an adverse cardiovascular phenotype in later life? Insights from UK biobank
2019
·
E Elmahi
, M M Sanghvi
, et al.
·
European Heart Journal
Cardiometabolic and reproductive health in young women: Making the right choices
2018
·
Einas Elmahi
, Paul Leeson
·
European Journal of Preventive Cardiology
PDF
Show more works
View as search
Works count:
25
Citation count:
3,987
H-index:
17
I10-index:
18
Year
Topic
Type
